Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy
- 1 July 2002
- Vol. 60 (1) , 84-88
- https://doi.org/10.1016/s0090-4295(02)01660-6
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs
This publication has 16 references indexed in Scilit:
- PERCENT PROSTATE NEEDLE BIOPSY TISSUE WITH CANCER IS MORE PREDICTIVE OF BIOCHEMICAL FAILURE OR ADVERSE PATHOLOGY AFTER RADICAL PROSTATECTOMY THAN PROSTATE SPECIFIC ANTIGEN OR GLEASON SCOREJournal of Urology, 2002
- Multivariate analysis of race and adverse pathologic findings after radical prostatectomyUrology, 2000
- Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical centerUrology, 2000
- Clinical Utility of the Percentage of Positive Prostate Biopsies in Defining Biochemical Outcome After Radical Prostatectomy for Patients With Clinically Localized Prostate CancerJournal of Clinical Oncology, 2000
- CAN PERINEURAL INVASION ON PROSTATE NEEDLE BIOPSY PREDICT PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY?Journal of Urology, 1999
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate CancerJNCI Journal of the National Cancer Institute, 1998
- Prediction of Extraprostatic Extension of Prostate Cancer Based on Needle Biopsy Findings:The American Journal of Surgical Pathology, 1997
- Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate CancerJAMA, 1997
- Evaluation of Radical Prostatectomy SpecimensThe American Journal of Surgical Pathology, 1992